Results

Total Results: 900 records

Showing results for "author year description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
    March 15, 2016 - The Symphony Trial conclusion states The Symphony study showed that at 1 year post transplant a regimen … Based on a 25 year heritage as a pioneer in transplant immunosuppression, we are sharing the following … Peer Reviewer 3 Introduction Page 3, Lines 27-28: the description of desensitization regimens should … Peer Reviewer 3 Conclusion A strong and succinct description of the risks and benefits of the various … We have revised the Conclusion to include a more useful description of the risks and benefits of different
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
    January 01, 2023 - After studies are screened and determined to meet inclusion criteria, we will abstract study design, year … Data Synthesis: Characteristics of included studies, such as number of publications by year, study sample … Author 2. Year of publication 3. Bibliographic citation 4. PubMed ID 5. … Year of publication 2. Study class 3. Country/Countries of study sites 4. Site type 5. … Treatment Description 4.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_disposition.pdf
    December 09, 2014 - In addition, note that the correct name of the author in ref 13 is Bucci not Burri. … A more detailed description of this process would be helpful. … and year in other instances. … We use the AHRQ convention for citations and refer to author and date when highlighting a specific … The SBRT description should be much better.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
    October 01, 2018 - This report is made available to the public under the terms of a licensing agreement between the author … ....................................................................... 2 Process Description .... … Results Final Product Description Health System Decision Aid The final health system decision … and explicit description of the population, its comorbidities and characteristics. … o Information available in reports but require more synthesis or emphasis:  Explicit description of
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
    December 31, 2022 - A complete description of the search strategy can be found in Appendix A. … Joanna Briggs Institute cohort checklist used in study screening Author, Year 1 2 3 4 5 6 7 … Risk of bias and overall study quality ratings Author Sampling Risk of Bias Cohort Allocation … Uncontrolled studies of reinfection from SARS-CoV-2 Author Title Country Population Graham, 202144 … This report is made available to the public under the terms of a licensing agreement between the author
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
    February 01, 2019 - Physical activity interventions Author, Year Study Design Intervention Duration Country Study Quality … C-2 Author, Year Study Design Intervention Duration Country Study Quality Population Intervention … C-3 Author, Year Study Design Intervention Duration Country Study Quality Population Intervention … Arts and recreation interventions Author, Year Study Design Intervention Duration Country Study … Health services access interventions Author, Year Study Design Intervention Duration Country Study
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
    November 27, 2012 - In the description of included studies section, we added a statement that “in 43 (61%) studies, migraine … In the description of included studies section, we added a statement that “in 43 (61%) studies, migraine … We added a statement in the description of included studies section that stated, “in 44 studies, migraine … In the description of included studies section, we added a statement that “in 43 (61%) studies, migraine … We have added the following information in the ES and main report (description of included studies)
  8. Project Name: (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
    October 25, 2011 - Our description of an association has been improved. … This may be a problem with clarity of description rather than the actual data. … We have expanded our description of these concepts in the introduction and added the above text to … Our clinical expert stands by our description. … Increased Incidence of Cardiovascular Disease in Middle- aged Men with Obstructive Sleep Apnea: A 7- Year
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
    November 01, 2013 - of the project or fiscal year of funding. … When trying to contact a study 19 author, there is little guidance as to how many times this … reviewers conducted by Mullan, et al.84 reported that most respondents contacted at least one study author … Trying to contact one study author three times and other study authors once is systematically different … FDA Web Site – Drugs@FDA Agency URL Description U.S.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
    January 07, 2013 - The audience of this report is not explicitly stated but assumed based on the general description of … Peer Reviewer #3 General Description of the studies suggests none was an RCT, but the table includes … The revised “Description of Included Studies” section for KQ2 states, “Thirty-three of the 48 studies … The report is generally very well-written and is exhaustive in the description of the approach. … As suggested, we have modified our description of the control group to clarify.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
    April 01, 2024 - We organized information according to the review questions, and noted the author, year, study design … Details of studies focused on hospital discharge care transitions Author, Year Risk of Bias Study … Details of studies focused on transfers from intensive care units Author, Year Risk of Bias … Details of studies focused on other care transitions Author, Year Risk of Bias Study Design … Patient safety practice implementation facilitators and barriers Author, Year Implementation Facilitators
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
    June 12, 2012 - The detailed description of the search strategies and key terms would allow for replication. … Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center … Safety of contrast agent use during stress echocardiography: a 4-year experience from a single- center … statement is incorrect given that there are about 1-2 million diagnostic angiograms performed each year … The methodology section has no description of the method used.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-disposition-comments.pdf
    November 22, 2024 - ● We made several word edits suggested by peer reviewers including refinement of the description … products/dietary-protein-intake/research Published Online: November 22, 2024 2 Public Comments and Author
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
    May 29, 2013 - We share some of the reviewers concern regarding the description of filter related thrombosis. … Despite these concerns we believe that such outcomes should be included with a nuanced description … - not to the best of my knowledge Thanks Reviewer 10 Results What was the span of publication year … patients (one is trauma and 1 is ortho trauma, but both are same years, same institition, same first author … propensity matched analysis which was one of the top ten studies presented at the ASMBS meeting this year
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
    December 01, 2010 - The findings and conclusions in this document are those of the author(s), who are responsible for its … Description of study design classification tools rejected for further evaluation................8 Table … Classification of studies: Round 1 Study (author, year) Reference Standard NonR trial RCT Prosp … Classification of studies: Round 1 (continued) Study (author, year) Reference Standard NonR … Classification of studies: Round 2 Study (author, year) Reference Standard NonR trial RCT Prosp
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
    January 15, 2015 - effectiveness reviews, and will include elements that address population characteristics including description … between the comparative groups or overall high loss to follow-up, and the validity and adequacy of the description … descriptions of the study design, intervention(s), mean baseline blood pressure and kidney function, description
  17. effectivehealthcare.ahrq.gov/sites/default/files/palliative-care-tools-disposition.pdf
    May 04, 2017 - Expand the description of each Domain here using the source document. … The author makes a conclusion there is no tool available for the legal aspects. … The authors should consider contacting the principle author to review their findings. … Not clear from the description. … very comprehensive review of patient experience tools that we used for this review, that covered the year
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/palliative-care-tools-disposition.pdf
    May 04, 2017 - Expand the description of each Domain here using the source document. … The author makes a conclusion there is no tool available for the legal aspects. … The authors should consider contacting the principle author to review their findings. … Not clear from the description. … very comprehensive review of patient experience tools that we used for this review, that covered the year
  19. effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Peer Reviewer #1 Executive Summary P24 Also, the description of KQ 2 is much smaller and does … I strongly object to the current wording, and as the first author of the CPG can definitively state … The first description on pg. 59 refers to the full matrix of treatment effects. … did not report any details beyond "Hearing levels were normal in all children, in both groups, at 1-year … Appendix tables have been regenerated, sorted Alphabetically by author TEP/KI Reviewer # 1
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Peer Reviewer #1 Executive Summary P24 Also, the description of KQ 2 is much smaller and does … I strongly object to the current wording, and as the first author of the CPG can definitively state … The first description on pg. 59 refers to the full matrix of treatment effects. … did not report any details beyond "Hearing levels were normal in all children, in both groups, at 1-year … Appendix tables have been regenerated, sorted Alphabetically by author TEP/KI Reviewer # 1

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: